Clinical Trials Logo

Cardiovascular Diseases clinical trials

View clinical trials related to Cardiovascular Diseases.

Filter by:

NCT ID: NCT01803711 Terminated - Cancer Clinical Trials

Omega 3 FA Supplements as Augmentation in the Treatment of Depression

Start date: February 2013
Phase: Phase 2/Phase 3
Study type: Interventional

To assess the efficacy of Omega 3 Fatty acid (Omega 3 FA) augmentation of desvenlafaxine (DVS) compared to placebo augmentation of DVS when used to treat depression and anxiety symptoms in patients with select medical conditions (cancer, cardiovascular diseases and diabetes).

NCT ID: NCT01802541 Completed - Type 2 Diabetes Clinical Trials

Effect of Diacylglycerol Oil on Risk Factors of Type 2 Diabetes and Complicating Disease, and Mechanism

Start date: n/a
Phase: N/A
Study type: Interventional

Diacylglycerol oil has been shown to lower postprandial and fasting serum triacylglycerol levels and reduce body fat. The investigators hypothesize that replacing dietary fat with diacylglycerol oil reduces excess body fat in type 2 diabetic patients and that diacylglycerol oil has a beneficial effect on cardiovascular risk factors in Chinese type 2 diabetic patients.

NCT ID: NCT01802372 Completed - Hypertension Clinical Trials

Task Shifting and Blood Pressure Control in Ghana

TASSH
Start date: May 1, 2012
Phase: N/A
Study type: Interventional

The goal of this study is to evaluate the comparative effectiveness of the World Health Organization Package targeted at Cardiovascular (CV) risk assessment and hypertension control, delivered by Community Health Nurses as part of Ghana's Community based Health Planning and Services program, versus provision of health insurance coverage, on blood pressure reduction. Findings from this study will provide policy makers and other stakeholders needed information to recommend efficient cost-effective policy with regards to comprehensive CV risk reduction in patients with hypertension in low resource settings.

NCT ID: NCT01801254 Completed - Obesity Clinical Trials

Using EEG Operant Conditioning to Improve Trait Self-Control and Promote Healthy Behavior

Start date: February 2013
Phase: Phase 1
Study type: Interventional

The field of neuroeconomics has begun to elucidate neural mechanisms underlying self-control; however, researchers have not yet harnessed neuroeconomics findings to develop interventions for improving self-control ability. The investigators are currently developing such an intervention. The investigators' approach involves using a brain-computer interface with audiovisual feedback to show people what is happening in their own brains, in real time. Through this interface, individuals are trained to increase levels of neural activity that may facilitate self-control, which, in turn, may improve the ability to exhibit self-controlled behaviors. This may increase the ability to engage in heath behaviors for which self-control is required (eg, dieting and exercising). The investigators' long-term goal is to create a tool that will help people develop the self-control needed to achieve lasting improvements in health behaviors.

NCT ID: NCT01800019 Active, not recruiting - HIV Clinical Trials

The Canadian HIV Quit Smoking Trial: Tackling the Co-morbidities of Depression and Cardiovascular Disease in HIV+ Smokers

CANQUIT
Start date: January 2014
Phase: Phase 3
Study type: Interventional

The objectives of this trial are: Primary objectives: 1. To determine among HIV+ individuals whether varenicline or NRT is more effective at helping individuals remain abstinent from smoking tobacco. 2. To determine among HIV+ individuals whether varenicline or NRT has the lowest side-effect profile. 3. To determine if the HIV tailored Quit Smoking Counselling Intervention, plus smoking cessation drug therapy, improves smoking cessation rates compared to smoking cessation drug therapy alone with usual care. Secondary objective: 1. To determine whether the use of varenicline/NRT is safe in HIV+ patients who exhibit depressive symptoms. Hypothesis: That varenicline will result in higher quit smoking rates and that NRT will result in a lower side effect profile. Further, the HIV tailored quit smoking intervention will result in higher rates of smoking cessation over and above the pharmacological treatment alone. And finally, varenicline will be safe to use for HIV + individuals who exhibit depressive symptoms.

NCT ID: NCT01797211 Completed - Clinical trials for Cardiovascular Diseases

Mediterranean Diet and Endothelial Function

Start date: June 2010
Phase: Phase 4
Study type: Interventional

To assess the effect of Mediterranean diet and some of its specific components (olive oil, non fried fish and nuts) on endothelial function in overweight and obese patients

NCT ID: NCT01786421 Completed - Clinical trials for Cardiovascular Diseases

Diurnal Triglyceridemia in Relation to Alcohol Intake

Start date: n/a
Phase: N/A
Study type: Observational

The purpose of this study is to determine the impact of alcohol consumption in diurnal triglyceridemia in a free living situation.

NCT ID: NCT01785537 Active, not recruiting - Clinical trials for Cardiovascular Diseases

The Efficacy and Safety of Electronic Cigarettes: a 5-year Follow-up Study

Start date: October 2013
Phase: N/A
Study type: Observational

The main aim of this multicentric 5-year follow-up study is to evaluate for the first time the long-term efficacy and safety (in terms of smoking-related serious diseases requiring hospitalization) of e-cigarette smoking, comparing its health effects with those of traditional cigarette smoking and mixed electronic and traditional cigarette smoking. The study will also permit to evaluate, over a 5-year follow-up, the self-reported quality of life, and the reported adverse events according to current and past smoking habit. Finally, the study will also explore the long-term adherence to e-cigarette smoking and its efficacy of e-cigarettes in reducing and/or quitting traditional cigarette smoking.

NCT ID: NCT01784796 Completed - Stroke Clinical Trials

Mindful Hearts Study: Mindfulness to Reduce Stress

Start date: July 1, 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine how a stress reduction program, called Mindfulness Based Stress Reduction (MBSR), compared to a health education program, improves well being and reduces the risk of heart disease in women Veterans. Recruitment completed.

NCT ID: NCT01784055 Completed - Clinical trials for Cardiovascular Diseases

NeoChord TACT Post-Market Surveillance Registry

Start date: March 2013
Phase:
Study type: Observational [Patient Registry]

To monitor the long-term performance of the CE Marked NeoChord Artificial Chordae Delivery System